Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Due to travel bans and health risk concerns, rescheduling this event will enable us to ensure an experience that all participants expect and deserve in a safe environment. We are pleased with and believe you will agree our online platform will be user friendly and a great experience for all of us.
We are eager to have you join us for this highly anticipated annual livestreamed event which features the top oncologists in their field presenting the most current and emerging information in targeted therapies and answering patient questions in real time. The rescheduled event will be September 12, 2020. More details will be forthcoming, and your registration will automatically be applied to the rescheduled event; there is no need to re-register.
Registration remains open at this time and as more information becomes available we will notify you.
The latest information about our Targeted Therapies Forum will always be available at www.cancergrace.org.
If you have any questions regarding your registration, please email us at info@cancerGRACE.org.
We look forward to having you join us in the fall. Until then, stay safe and healthy!
This event will be held LIVE ONLINE
For Details - Please View the full Agenda and the Faculty Information for more information!
Please feel free to offer comments and raise questions in our
discussion forums.
Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...
The prefix “oligo–” means few. Oligometastatic (at diagnosis) Oligoprogression (during treatment)
There will be a discussion, “Studies in Oligometastatic NSCLC: Current Data and Definitions,” which will focus on what we...
Radiation therapy is primarily a localized treatment, meaning it precisely targets a specific tumor or area of the body, unlike systemic treatments (like chemotherapy) that affect the whole body.
The...
Biomarkers are genetic mutations (like EGFR, ALK, KRAS, BRAF) or protein levels (like PD-L1) in tumor cells that help guide personalized treatment, especially NSCLC, directing patients to targeted therapies or immunotherapies...
Hi Stan! So good to hear from you. I'm sorry for the late response. I too have been out of town with family and missed your post, probably because I was...
It is so good to hear from you! And I am so happy to hear that your holidays have been good and that you are doing well. It sounds like your...
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components: